N-acetylcysteine reduces oxidative stress in sickle cell patients
Open Access
- 10 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Hematology
- Vol. 91 (7), 1097-1105
- https://doi.org/10.1007/s00277-011-1404-z
Abstract
Oxidative stress is of importance in the pathophysiology of sickle cell disease (SCD). In this open label randomized pilot study the effects of oral N-acetylcysteine (NAC) on phosphatidylserine (PS) expression as marker of cellular oxidative damage (primary end point), and markers of hemolysis, coagulation and endothelial activation and NAC tolerability (secondary end points) were studied. Eleven consecutive patients (ten homozygous [HbSS] sickle cell patients, one HbSβ0-thalassemia patient) were randomly assigned to treatment with either 1,200 or 2,400 mg NAC daily during 6 weeks. The data indicate an increment in whole blood glutathione levels and a decrease in erythrocyte outer membrane phosphatidylserine exposure, plasma levels of advanced glycation end-products (AGEs) and cell-free hemoglobin after 6 weeks of NAC treatment in both dose groups. One patient did not tolerate the 2,400 mg dose and continued with the 1,200 mg dose. During the study period, none of the patients experienced painful crises or other significant SCD or NAC related complications. These data indicate that N-acetylcysteine treatment of sickle cell patients may reduce SCD related oxidative stress.Keywords
This publication has 47 references indexed in Scilit:
- Plasma levels of advanced glycation end products are associated with haemolysis‐related organ complications in sickle cell patientsBritish Journal of Haematology, 2010
- Development and validation of a pediatric severity index for sickle cell patientsAmerican Journal of Hematology, 2010
- Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stressDiabetologia, 2010
- Heme degradation and oxidative stress in murine models for hemoglobinopathies: Thalassemia, sickle cell disease and hemoglobin C diseaseBlood Cells, Molecules, and Diseases, 2008
- N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell diseaseBlood, 2008
- Mechanisms of Vasculopathy in Sickle Cell Disease and ThalassemiaHematology, 2008
- Advanced glycation end-products in sickle cell anaemiaBritish Journal of Haematology, 2005
- Nutritional and Metabolic Aspects of GlutathioneAnnual Review of Nutrition, 1989
- Spontaneous oxygen radical generation by sickle erythrocytes.JCI Insight, 1982